Analyst Upgrades – VRX – Valeant Pharmaceuticals International (NYSE:VRX) Stock Gets Upgraded By Mizuho from Underperform to Neutral

ME Staff
-
0

Analyst Ratings For VRX – Valeant Pharmaceuticals International (NYSE:VRX)

Today, VRX – Valeant Pharmaceuticals International (NYSE:VRX) stock received an upgrade by Mizuho from Underperform to Neutral with a price target of $15.00.

Some recent analyst ratings include

  • 4/6/2018-Mizuho Upgrade from a “Underperform ” rating to a ” Neutral” rating.
  • 3/20/2018-Wells Fargo Reiterated Rating of Sell.
  • 3/15/2018-HC Wainwright Reiterated Rating of Hold.
  • 3/1/2018-Piper Jaffray Reiterated Rating of Sell.
  • 2/28/2018-Cfra was Downgraded by analysts at Cfra from a “Hold” rating to a “” rating.

Recent Insider Trading Activity For VRX – Valeant Pharmaceuticals International (NYSE:VRX)
VRX – Valeant Pharmaceuticals International (NYSE:VRX) has insider ownership of 5.87% and institutional ownership of 50.10%.

  • On 3/13/2018 Joseph C Papa, CEO, bought 30,000 with an average share price of $16.05 per share and the total transaction amounting to $481,500.00.
  • On 3/13/2018 Paul Herendeen, CFO, bought 15,000 with an average share price of $16.10 per share and the total transaction amounting to $241,500.00.
  • On 3/8/2018 Schutter Richard U De, Director, bought 10,000 with an average share price of $15.34 per share and the total transaction amounting to $153,400.00.
  • On 3/6/2018 John Paulson, Director, bought 7,066,629 with an average share price of $15.40 per share and the total transaction amounting to $108,826,086.60.
  • On 11/16/2017 John Paulson, Director, bought 344,216 with an average share price of $14.40 per share and the total transaction amounting to $4,956,710.40.
  • On 8/21/2017 Schutter Richard U De, Director, bought 10,000 with an average share price of $14.33 per share and the total transaction amounting to $143,300.00.
  • On 5/11/2017 Schutter Richard U De, Director, bought 20,000 with an average share price of $13.90 per share and the total transaction amounting to $278,000.00.

Recent Trading Activity for VRX – Valeant Pharmaceuticals International (NYSE:VRX)
Shares of VRX – Valeant Pharmaceuticals International closed the previous trading session at 15.74 down -0.05 0.32% with 15.699999809265137 shares trading hands.